HR
BMY icon

Hardy Reed’s Bristol-Myers Squibb BMY Stock Holding History

Hardy Reed’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$506K Buy
8,346
+269
+3% +$15.7K 0.04% 141
2025
Q4 		$436K Buy
8,077
+263
+3% +$12.7K 0.03% 153
2025
Q3 		$352K Buy
7,814
+1,125
+17% +$52.5K 0.03% 179
2025
Q2 		$310K Buy
6,689
+61
+0.9% +$2.99K 0.02% 181
2025
Q1 		$404K Buy
6,628
+123
+2% +$7.17K 0.04% 149
2024
Q4 		$368K Buy
6,505
+70
+1% +$3.91K 0.03% 161
2024
Q3 		$333K Buy
6,435
+105
+2% +$4.93K 0.03% 173
2024
Q2 		$263K Buy
+6,330
New +$283K 0.03% 200

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hardy Reed's BMY Position: Q1 2026 in Review

Hardy Reed increased its Bristol-Myers Squibb (BMY) stake by 3.3% in Q1 2026, buying an estimated $15.7K and bringing the position to 8,346 shares worth $506K. The position accounts for 0.04% of the portfolio, ranked #141.

Hardy Reed first reported a position in BMY in Q2 2024 and has held it in 8 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Hardy Reed held 8,346 shares of Bristol-Myers Squibb worth $506K as of Q1 2026.
  • Hardy Reed bought 269 Bristol-Myers Squibb shares in Q1 2026, an estimated $15.7K.
  • Bristol-Myers Squibb made up 0.04% of Hardy Reed's portfolio in Q1 2026, its #141 holding.
  • Hardy Reed first reported a position in Bristol-Myers Squibb in Q2 2024 and has held it in 8 quarters since.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Hardy Reed's 13F filing for Q1 2026, filed 28 Apr 2026.